Balyasny Asset Management LLC Moderna, Inc. Transaction History

Balyasny Asset Management LLC

$54.9 Billion
Q2 2024

A detailed history of Balyasny Asset Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 13,300 shares of MRNA stock, worth $874,475. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,300

Previous 10,300 29.13%

Holding current value

$874,475

Previous $1.1 Million 43.94%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $3.04 Million - $5.01 Million	30,076 Added 292.0%	40,376 $4.79 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $879,311 - $1.19 Million	10,300 New	10,300 $1.1 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $37.3 Million - $49 Million	386,625 Added 123.24%	700,341 $72.3 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $36.6 Million - $49.5 Million	308,504 Added 5919.11%	313,716 $38.1 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $20.3 Million - $29.5 Million	-149,900 Reduced 96.64%	5,212 $800,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $18.4 Million - $32.6 Million	155,112 New	155,112 $27.9 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $3.41 Million - $5.15 Million	-29,152 Reduced 43.82%	37,377 $5.34 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $15 Million - $24.5 Million	66,529 New	66,529 $16.9 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $26.2 Million - $45.7 Million	-481,631 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $14.3 Million - $38.5 Million	481,631 New	481,631 $30.9 Million
Q4 2019 Feb 14, 2020	SELL	$13.93 - $21.28 $160,989 - $245,932	-11,557 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $458,769 - $676,179	-37,420 Reduced 76.4%	11,557 $184,000
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $670,984 - $1.39 Million	48,977 New	48,977 $717,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Moderna, Inc. Transaction History